Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study

[1] Lawn SD(2008)Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa AIDS 22 1897-908

[2] Harries AD(2008)Adherence to antiretroviral therapy in Africa: how high is it really? Trop Med Int Health 13 1096-7

[3] Anglaret X(2010)Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial Lancet 375 123-31

[4] Myer L(2009)Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial Lancet 374 2080-9

[5] Wood R(2008)Integrating research into routine service delivery in an antiretroviral treatment programme: lessons learnt from a cluster randomized trial comparing strategies of HIV care in Jinja, Uganda Trop Med Int Health 13 795-800

[6] Jaffar S(2007)A cluster-randomised trial to compare home-based with health facility-based antiretroviral treatment in Uganda: study design and baseline findings Open AIDS J 1 21-7

[7] Munderi P(1999)The use of fractional polynomials to model continuous risk variables in epidemiology Int J Epidemiol 28 964-74

[8] Grosskurth H(2006)Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries Lancet 367 817-24

[9] Mugyenyi P(2009)Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda BMC Public Health 9 290-15

[10] Walker AS(2011)Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review PLoS Med 8 e1001056-9

[1] Lawn SD(2008)Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa AIDS 22 1897-908

[2] Harries AD(2008)Adherence to antiretroviral therapy in Africa: how high is it really? Trop Med Int Health 13 1096-7

[3] Anglaret X(2010)Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial Lancet 375 123-31

[4] Myer L(2009)Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial Lancet 374 2080-9

[5] Wood R(2008)Integrating research into routine service delivery in an antiretroviral treatment programme: lessons learnt from a cluster randomized trial comparing strategies of HIV care in Jinja, Uganda Trop Med Int Health 13 795-800

[6] Jaffar S(2007)A cluster-randomised trial to compare home-based with health facility-based antiretroviral treatment in Uganda: study design and baseline findings Open AIDS J 1 21-7

[7] Munderi P(1999)The use of fractional polynomials to model continuous risk variables in epidemiology Int J Epidemiol 28 964-74

[8] Grosskurth H(2006)Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries Lancet 367 817-24

[9] Mugyenyi P(2009)Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda BMC Public Health 9 290-15

[10] Walker AS(2011)Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review PLoS Med 8 e1001056-9